Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Anticancer Research|March 29, 2022
The Trend of Combined Modality Treatment and its Outcomes in Elderly Patients With Primary CNS Lymphoma: A 12-year Population-based Analysis Using Propensity ScoreYazan Samhouri, Moaath K Mustafa Ali, Cyrus Khan, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2022
Consolidative Autologous Stem Cell Transplantation Versus Whole Brain Radiation in PCNSL; a Nationwide AnalysisYazan Samhouri, Moaath K Mustafa Ali, Jennie Law, et al.
Anti-Cancer Drugs|October 18, 2022
Venetoclax-induced vitiligo in a patient with chronic lymphocytic leukemiaMuath Abdeen, Urwat Til Vusqa, Palash Asawa, et al.
Hematology/Oncology and Stem Cell Therapy|April 6, 2023
Treatment Selection and Survival in Patients with Gray Zone Lymphoma: A Comprehensive Population-Based AnalysisYazan Samhouri, Thejus T Jayakrishnan, Lynna Alnimer, et al.
Journal of Hematology|April 22, 2024
Successful Treatment of Refractory Post-Transplant Lymphoproliferative Disorder With Chimeric Antigen Receptor T-Cell Therapy in a Heart Transplant RecipientKatherine Hickmann, Ryan Sweeney, Chelsea Peterson, et al.
Breast Cancer (Tokyo, Japan)|July 5, 2022
Patterns of treatment and their outcomes in primary breast lymphoma; a comprehensive population-based analysisMoaath K Mustafa Ali, Yazan Samhouri, Jennie Y Law, et al.
Cancer Medicine|August 19, 2014
Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemiaSanthosh K Sadashiv, Christie Hilton, Cyrus Khan, et al.
Cureus|May 31, 2022
Predictors and Long-Term Outcomes for Diffuse Large B-Cell Lymphoma (DLBCL) Patients Undergoing Surgery Prior to Systemic Therapy: A Nationwide AnalysisUrwat Vusqa, Thejus T Jayakrishnan, Veli Bakalov, et al.
American Journal of Translational Research|June 12, 2023
Incidence of malignant pericardial effusion in pericardiocentesis patients and post-procedure care: an oncology center pilot studyGohar Jamil, Sarah Jamil, Aqeel Saleem, et al.
Blood Advances|March 31, 2022
Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphomaAnas Younes, John M Burke, Catherine Diefenbach, et al.
Pageof 3